Current partner codePEPTIDESDE

Therapeutic-area index

PainPeptide Trials.

Explore peptide clinical trials tagged to the pain condition group in the current local registry snapshot. Condition groups are PeptideStat search classifications layered over source-reported indications.

Studies
57
Recruiting
9
Completed
21
Results posted
11
Countries
24
Avg enrollment
114

Velocity

Pain trials by start year

Study start year · indexed snapshot

8642020012001: 1 trials2002: 1 trials2003: 0 trials2004: 1 trials2005: 0 trials20062006: 0 trials2007: 0 trials2008: 1 trials2009: 2 trials2010: 0 trials20112011: 1 trials2012: 0 trials2013: 1 trials2014: 4 trials2015: 0 trials20162016: 3 trials2017: 1 trials2018: 4 trials2019: 4 trials2020: 5 trials20212021: 2 trials2022: 4 trials2023: 2 trials2024: 4 trials2025: 7 trials20262026: 8 trials20272027: 1 trials

Development

Trials by phase

Early Phase 11
Phase 13
Phase 221
Phase 37
Phase 47

Industry

Leading sponsors

Elan Pharmaceuticals2
Araim Pharmaceuticals, Inc.1
Eisai Limited1
Eli Lilly1
ESTEVE Pharmaceuticals SAS1
Jazz Pharmaceuticals1
KeyBioscience AG1
Neurex1

Therapeutic areas

Condition groups

Pain57
Inflammation5
Brain health4
Weight loss3
Longevity1

Study explorer

Search this collection.

57 matching studies